Medical Research Agency has signed a letter of intent with Wroclaw Medical University
Medical Research Agency has signed a letter of intent with Wroclaw Medical University on cooperation in terms of implementation of the "Medical Research Agency" project (task no. 2) within the PO WER project.
A draft act on clinical research was sent to the Minister of Health
The works on the draft act on clinical research on medicinal products have been finalised. They were carried as a part of implementation of the Clinical Research Development Programme prepared by the Medical Research Agency. The team for preparation of the draft act, nominated by the Minister of Health, on Wednesday (29 January) delivered a ready concept to the Minister.
Appointment of National Representatives for the POLCRIN entity
In connection with Poland's accession to the European Clinical Research Infrastructure Network (ECRIN) on 23 August 2019 for a period of three years in the role of an observer, the Medical Research Agency has created the POLCRIN entity (Eng. Polish Clinical Research Infrastructure Network).
Medical Research Agency summarises the work done and reveals plans for the oncoming year
As soon as on 4 December a conference of the Medical Research Agency titled "New opportunities for the development of medical and health sciences - WHERE ARE WE? WHERE ARE WE HEADING?" will be held. During this event, the Agency will summarise its activities and present plans for the year 2020.
The first PLN 100 million for non-commercial clinical research. Competition of the Medical Research Agency
Medical Research Agency has allocated PLN 100 million for the first competition in the area of supporting non-commercial clinical research. The funds will be channelled to patients through the leading research centres in Poland. The subsidy may be granted to projects in the area of paediatrics, neonatology, neurology, haematology, radiation therapy, oncology and cardiology
Ministry of Health and Medical Research Agency invite to the "Cancer Prevention 2020" Conference
Cancer prevention is one of the most important issues of the cancer treatment policy of the Government and countries of the European Union, Western Europe and also of the United States - stresses Radosław Sierpiński, MD, PhD, acting President of the Medical Research Agency during initiation of the "Cancer Prevention 2020" Conference.
Medical Research Agency has signed a letter of intent that supports development of innovation
The Medical Research Agency has signed a letter of intent declaring cooperation with representatives of key pharmaceutical companies in Poland in the field of developing the innovation of Polish medicine.
Polish accession to the European Clinical Research Infrastructure Network (ECRIN)
During the 29th Economic Forum in Krynica-Zdrój, through the Medical Research Agency, Poland will sign an agreement with the European Clinical Research Infrastructure Network (ECRIN). The undertaken actions will enable Poland to obtain the status of an observer and then of a member of the ECRIN network, which is an international agency that promotes a network of clinical research in Europe.
Medical Research Agency at the 29th Economic Forum in Krynica-Zdrój
Health care is one of the key subjects discussed during the Economic Forum in Krynica. The Medical Research Agency, as a part of the program of the 29th edition of the event, shall host the following panel: "Research and development in biotechnology as a leading branch of the country's innovative economy", that will take place on 4 September 2019, at 13:10.
Joint projects of MRA and National Institutes of Health in the USA
Prevention of cancers and cardiac diseases, innovation implementation in medicine, organisation of the health care system and joint clinical research - these were the subjects discussed during the meetings of the Medical Research Agency with health care institutions in the USA. The talks were held at the University of Texas - MD Anderson Cancer Center, with the Department of Health and Human Services (DHHS) and the National Institute of Health (NIH).